Monopar Therapeutics Inc (MNPR)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -2.41M | -2.91M | -2.53M | -2.33M | -2.07M | -1.91M | -1.72M | -1.79M |
税引前収入 | -2.4M | -2.89M | -2.44M | -2.2M | -1.95M | -1.81M | -1.64M | -1.72M |
純利益 | -2.4M | -2.89M | -2.44M | -2.2M | -1.95M | -1.81M | -1.64M | -1.72M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -2.41M | -2.91M | -2.53M | -2.33M | -2.07M | -1.91M | -1.72M | -1.79M |
EBITDA | -2.41M | -2.91M | -2.53M | -2.33M | -2.07M | -1.91M | -1.72M | -1.79M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 122k | 0 | 0 | 0 |
営業利益 | -16.6M | -3.4M | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
税引前収入 | -16.56M | -3.3M | -4.23M | -6.32M | -9.1M | -10.5M | -8.4M |
純利益 | -16.56M | -3.23M | -4.23M | -6.31M | -9.1M | -10.5M | -8.4M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.782 | -0.347 | -0.399 | -0.551 | -0.723 | -0.811 | -0.565 |
EBIT | -16.6M | -3.4M | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
EBITDA | -16.6M | -3.4M | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約